Acute Effects of Blood Flow Restriction Training to Failure on Hypoalgesia in Patients With Severe Knee Osteoarthritis Using Dynamic or Fixed Occlusion Pressure
NCT ID: NCT07300384
Last Updated: 2025-12-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
45 participants
INTERVENTIONAL
2026-01-31
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exercise to failure under low load resistance with moderate blood occlusion and dynamic pressure.
A single exercise session to failure, 30% of maximum repetition, 50% blood occlusion and dynamic pressure.
Low-intensity resistance exercise to failure with moderate arterial occlusion pressure and dynamic pressure.
A single quadriceps extension exercise at 30% of 1 repetition maximum (1RM) with dynamic occlusion at 50% of limb occlusion pressure (LOP). The exercise protocol will consist of 4 sets to muscle failure with 30 seconds of rest between sets and a continuous level of occlusion.
Exercise to failure under low load resistance with moderate blood occlusion and fixed pressure.
A single exercise session to failure, 30% of maximum repetition, 50% blood occlusion and fixed pressure.
Low-intensity resistance exercise to failure with moderate arterial occlusion pressure and fixed pressure.
A single quadriceps extension exercise at 30% of 1 repetition maximum (1RM) with fixed occlusion at 50% of limb occlusion pressure (LOP). The exercise protocol will consist of 4 sets to muscle failure with 30 seconds of rest between sets and a continuous level of occlusion.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Low-intensity resistance exercise to failure with moderate arterial occlusion pressure and dynamic pressure.
A single quadriceps extension exercise at 30% of 1 repetition maximum (1RM) with dynamic occlusion at 50% of limb occlusion pressure (LOP). The exercise protocol will consist of 4 sets to muscle failure with 30 seconds of rest between sets and a continuous level of occlusion.
Low-intensity resistance exercise to failure with moderate arterial occlusion pressure and fixed pressure.
A single quadriceps extension exercise at 30% of 1 repetition maximum (1RM) with fixed occlusion at 50% of limb occlusion pressure (LOP). The exercise protocol will consist of 4 sets to muscle failure with 30 seconds of rest between sets and a continuous level of occlusion.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of severe gonarthrosis according to the clinical and radiographic criteria of the American College of Rheumatology guidelines.
* On the waiting list for unilateral total knee replacement (TKR) surgery
Exclusion Criteria
* Previous hip or knee replacement surgery and osteotomy within the last year.
* Autoimmune arthritis
* Medical conditions that contraindicate exercise.
* Participation in exercise programs (\>2 days/week with training at intensities of 10-15 1RM) in the previous six months.
* History of stroke, brain surgery, major depression, or self-reported cognitive impairment that could affect performance in the study.
* Cardiovascular, thrombotic, or vascular risk factors (uncontrolled hypertension, peripheral arterial disease, history of deep vein thrombosis or pulmonary embolism, heart failure, severe varicose veins, or uncontrolled anticoagulant therapy).
* Skin or local alterations at the cuff application site (ulcers, open wounds, infections, lymphedema, or severe edema).
* Inability to communicate normally or with impaired communication skills.
50 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Valencia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Adrián Escriche Escuder
Assistant professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Valencia
Valencia, Valencia, Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025-FIS-3957418
Identifier Type: -
Identifier Source: org_study_id